Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Lantheus Holdings Inc LNTH

Lantheus Holdings, Inc. is a radiopharmaceutical-focused company. The Company is engaged in delivering science to enable clinicians to find, fight and follow disease to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Its Radiopharmaceutical Oncology diagnostics and therapeutic... see more

Recent & Breaking News (NDAQ:LNTH)

Lantheus Presents New Data on the Effectiveness of Novel PET Cardiac Imaging Agent Flurpiridaz F 18 in Obese Patients with Suspected Heart Disease at ACC Scientific Session

Business Wire April 4, 2016

Lantheus Holdings Announces Appointment of Jack Crowley as Chief Financial Officer

Business Wire March 28, 2016

Lantheus Holdings Announces Retirement of Director Dr. Patrick O'Neill; Appoints Two New Board Members

Business Wire March 8, 2016

Lantheus Holdings, Inc. Reports 2015 Fourth Quarter and Full Year Financial Results; Provides 2016 Guidance

Business Wire February 22, 2016

Lantheus Holdings, Inc. to Participate in the 2016 RBC Capital Markets' Global Healthcare Conference

Business Wire February 9, 2016

Lantheus Holdings to Host Fourth Quarter and Full Year 2015 Earnings Conference Call and Provide 2016 Guidance on February 22, 2016 at 4:30 p.m. Eastern Time

Business Wire February 8, 2016

Lantheus Holdings Announces Divestiture of Its Canadian Radiopharmacy Operations and Commencement of Long-Term Supply Agreement

Business Wire January 13, 2016

Lantheus Holdings Announces Appointment of Jack Crowley as Interim Chief Financial Officer

Business Wire December 10, 2015

Lantheus Presents New Data on the Effectiveness of Novel PET Cardiac Imaging Agent Flurpiridaz F 18 in Women with Suspected Heart Disease at AHA Scientific Sessions 2015

Business Wire November 8, 2015

Lantheus Holdings, Inc. Reports 2015 Third Quarter Financial Results

Business Wire November 4, 2015

Lantheus to Present New Data on the Effectiveness of Novel PET Cardiac Imaging Agent Flurpiridaz F 18 in Women with Suspected Heart Disease at the American Heart Association 2015 Scientific Sessions

Business Wire November 2, 2015

Lantheus Holdings, Inc. to Present at 24th Annual Credit Suisse Healthcare Conference

Business Wire October 30, 2015

Lantheus Holdings to Host Third Quarter 2015 Earnings Conference Call on November 4, 2015 at 4:30 P.M. Eastern Time

Business Wire October 21, 2015

Lantheus Holdings, Inc. to Present at Upcoming Investor Conferences

Business Wire August 31, 2015

Lantheus Holdings Announces Appointment of Mary Anne Heino as President and Chief Executive Officer

Business Wire August 28, 2015

Lantheus Holdings, Inc. Reports 2015 Second Quarter Financial Results

Business Wire August 4, 2015

Lantheus Holdings to Host Second Quarter 2015 Earnings Conference Call on August 4, 2015 at 4:30 p.m. Eastern Time

Business Wire July 21, 2015

Entellus Medical Appoints John Bakewell to Its Board of Directors

GlobeNewswire July 9, 2015

Lantheus Holdings Appoints New Member to Its Board of Directors

Marketwired July 9, 2015